COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,928 Articles (22,054 medRxiv, 7,874 bioRxiv)

Most recent first Previous |  Page 209: Articles 2081-2090  | Next

Cooperativity and induced oligomerisation control the interaction of SARS- CoV-2 with its cellular receptor and patient-derived antibodies
Asor, R., Olerinyova, A., Burnap, S. A., Kushwah, M. S., Soltermann, F., Rudden, L. P., Hensen, M., Vasiljevic, S., Brun, J., Hill, M., Chang, L., Dejnirattisai, W., Supasa, P., Mongkolsapaya, J., Zhou, D., Stuart, D. I., Screaton, G., Degiacomi, M., Zitzmann, N., Benesch, J. L., Struwe, W. B., Kukura, P.
10.1101/2023.09.14.557399 — Posted: 2023-09-15
The SARS-CoV-2 nucleoprotein associates with anionic lipid membranes
Dutta, M., Su, Y., Voth, G. A., Stahelin, R. V.
10.1101/2023.09.15.557899 — Posted: 2023-09-15
Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine booster
Wang, X., Jiang, S., Ma, W., Li, X., Wei, K., Xie, F., Zhao, C., Zhao, X., Li, C., Qiao, R., Cui, Y., Chen, Y., Li, J., Cai, G., Liu, C., Hu, Z., Zhang, W., Li, M., Zhang, Y., Wang, P.
10.1101/2023.09.14.557682 — Posted: 2023-09-15
Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics
Ose, N. J., Campitelli, P. J., Modi, T., Kazan, I. C., Kumar, S., Ozkan, S. B.
10.1101/2023.09.14.557827 — Posted: 2023-09-15
Trajectories and correlates of poor mental health in India over the course of the COVID-19 pandemic: a nation-wide survey
Nichols, E., Petrosyan, S., Khobragade, P., Banerjee, J., Angrisani, M., Dey, S., Bloom, D., Schaner, S., Dey, A., Lee, J.
10.1101/2023.09.13.23295513 — Posted: 2023-09-14
The impact of the COVID-19 pandemic on short-term cancer survival in the United Kingdom: a cohort analysis
Barclay, N. L., Burkard, T., Burn, E., Delmestri, A., Dominguez, A. M., Golozar, A., Guarner-Argente, C., Aviles-Jurado, F.-X., Man, W. Y., Rosello Serrano, A., Weinberger Rosen, A., Tan, E. H., Tietzova, I., OPTIMA Consortium, , PRIETO-ALHAMBRA, D., Newby, D.
10.1101/2023.09.14.23295563 — Posted: 2023-09-14
Estimating the population effectiveness of interventions against COVID-19 in France: a modelling study
Ganser, I., Buckeridge, D. L., Heffernan, J. M., Prague, M., Thiebaut, R.
10.1101/2023.09.14.23295425 — Posted: 2023-09-14
How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023.
Johnson-Hall, E.
10.1101/2023.09.14.23295542 — Posted: 2023-09-14
Factors associated with teenage pregnancies during the Covid-19 period in Pakwach district, Northern Uganda: a case-control study
Alunyo, J. P., Mukunya, D., Napyo, A., Matovu, J. K., Okia, D., Wanume, B., Okello, F., Tuwa, A. H., Wenani, D., Okibure, A., Omara, G., Olupot Olupot, P.
10.1101/2023.09.13.23295521 — Posted: 2023-09-14
Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic
Crits-Christoph, A., Levy, J. I., Pekar, J., Goldstein, S. A., Singh, R., Hensel, Z., Gangavarapu, K., Rogers, M. B., Moshiri, N., Garry, R. f., Holmes, E. C., Koopmans, M. P. G., Lemey, P., Popescu, S., Rambaut, A., Robertson, D. L., Suchard, M. A., Wertheim, J., Rasmussen, A. L., Andersen, K. G., Worobey, M., Debarre, F.
10.1101/2023.09.13.557637 — Posted: 2023-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).